Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | thioredoxin reductase, putative | 0.0108 | 0.0561 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0302 | 0.5445 | 0.9738 |
Loa Loa (eye worm) | hypothetical protein | 0.0308 | 0.5592 | 1 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0175 | 0.2263 | 0.5722 |
Plasmodium falciparum | glutathione reductase | 0.0108 | 0.0561 | 0.5 |
Schistosoma mansoni | ryanodine receptor related | 0.0316 | 0.5799 | 0.7496 |
Plasmodium falciparum | thioredoxin reductase | 0.0108 | 0.0561 | 0.5 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.0266 | 0.4555 | 1 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0226 | 0.3536 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0108 | 0.0561 | 0.1003 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0226 | 0.3536 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0108 | 0.0561 | 0.1003 |
Loa Loa (eye worm) | hypothetical protein | 0.0257 | 0.4319 | 0.7724 |
Loa Loa (eye worm) | hypothetical protein | 0.0226 | 0.3536 | 0.6324 |
Plasmodium vivax | glutathione reductase, putative | 0.0108 | 0.0561 | 0.5 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0393 | 0.7737 | 1 |
Brugia malayi | Ryanodine Receptor TM 4-6 family protein | 0.0316 | 0.5799 | 0.555 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0108 | 0.0561 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0181 | 0.241 | 1 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0175 | 0.2263 | 0.5722 |
Toxoplasma gondii | thioredoxin reductase | 0.0108 | 0.0561 | 0.5 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.0266 | 0.4555 | 1 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.0257 | 0.4319 | 0.5582 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.